EAHP Needs assessment survey 2021

To assist us with planning for future congresses, please select the topics which would most benefit your learning needs. You may select as many topics as you wish.

The survey sections below are based on the EAHP European Statements of Hospital Pharmacy. For more information on the Statements, please click here: http://statements.eahp.eu

Deadline to fill it in is May 5th, 2021.

Question Title

* 1. Section 1: Introductory Statements and Governance

Case studies of hospital pharmacy practice in other European countries

Developments in Hospital Pharmacy outside of Europe e.g. North America, Asia, Middle East, etc.

Health Technology assessment (HTA).

Horizon scanning conceptual issues of hospital pharmacist profession e.g. reforming hospital pharmacy for an ageing society

Hospital pharmacy finance, management and administration issues

Hospital pharmacy management

Interfaces to various disciplines and professions

Pharmacy and data mining

Information Technology (IT) solutions for hospital pharmacies (e.g., ERP-systems, Electronic Patient Record, production, tenders, order entry etc.)

LEAN model applied to hospital pharmacy

Solving common problems in hospital pharmacy e.g. medicines shortages, finance, communication

Other (please specify)

Question Title

* 2. Section 2: Selection, Procurement and Distribution

Barcoding and closed loop medication

Drug shortages

Cost of new treatments and budget constraints

Introducing new technology into the hospital pharmacy*

Selection and use of Medical Devices

Other (please specify)

Question Title

* 3. Section 3: Production and compounding

Analytics / Quality Control

Automation of production

Hospital pharmacy medicines production

Introducing new technology into the hospital pharmacy*

Oncology pharmacy issues*

Ready to use drugs*

Other (please specify)

Question Title

* 4. Section 4: Clinical Pharmacy Services

Antimicrobial treatment

Patients with chronic ilnesses and continuity of care

Clinical pharmacy in Critical Care

Conduct and results of clinical trials

Dendritic cell therapy

Drugs in pregnancy and lactation

HIV transmission prevention

Medication Reconciliation

Computerized Physician Order Entry (CPOE) and Clinical Decision Support Systems (CDSS)

Medicine adherence

Medicines for children

Medicines for older patients

Pharmacotherapy updates

Artificial nutrition (TPN and EN)

Ocular disorder treatment

Oncology pharmacy issues*

Service and drug delivery to home patients

Targeted therapy and immunotherapy

New treatments in oncoematology

Treatments for Hemophilia

Off label use of medicines

Wound healing

Other (please specify)

Question Title

* 5. Section 5: Patient Safety and Quality Assurance

Computerized Physician Order Entry (CPOE) and Clinical Decision Support Systems (CDSS)

Therapeutic education of the patient and patient enpowerment

Ready to use drugs*

Risk management

Medication errors

Pharmacovigilance

Medical devices vigilance

Patient safety and seamless care

Toxicology

Other (please specify)

Question Title

* 6. Section 6: Education and Research

Academic training as continuing education tool

Update on EU legislation on clinical trials and human research

Distance learning, lifelong learning

Patient centered learning

Postgraduate training of HP and documentation of competencies

Professional development issues e.g. sessions on improving communication skills, etc.

Therapeutic education of the patient

Other (please specify)